[Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
D000818:Animals; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology / Q000627:therapeutic use*; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use*; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Aktivnost' preparatov vtorogo riada, etambutola i rifampitsina pri eksperimental'nom tuberkuleze, vyzvannom vysokoustoĭchivymi k osnovnym tuberkulostaticheskim preparatam Mikobakteriiami tuberkuleza.